Paper Details

  1. Home
  2. Paper Details

Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.

Author: BagnascoM, BuscagliaS, CanonicaG W, CatrulloA, CiprandiG, FiorinoN, MontagnaP, PesceG

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study focuses on the effects of azelastine, a selective H1-receptor antagonist, on ICAM-1 expression on epithelial cells, which is a key factor in the inflammatory response to nasal allergens.
Paper Details　
Original Abstract of the Article :
Azelastine is a selective H1-receptor antagonist, which has previously been demonstrated to be effective in the treatment of allergic rhinitis. We have recently demonstrated that nasal azelastine inhibits the clinical and inflammatory events following nasal allergen challenge. Particularly, we focus...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/9061218

データ提供：米国国立医学図書館（NLM）

Azelastine Eye Drops: A Potential Solution for Allergic Conjunctivitis

Allergic conjunctivitis, a common and often bothersome eye condition, can significantly affect an individual's quality of life. This research investigates the potential of azelastine eye drops as a treatment for allergic conjunctivitis, exploring its ability to reduce and prevent allergic reactions and exert anti-allergic activity. Think of this research as a scientific expedition into the world of ocular allergies, seeking a safe and effective solution to alleviate this common eye condition.

Azelastine: Targeting the Root of Allergic Conjunctivitis

The study's findings suggest that azelastine eye drops can effectively reduce and prevent allergic conjunctivitis, offering a potential relief for those struggling with this condition. The researchers found that azelastine effectively blocks the action of histamine, a key chemical mediator involved in allergic reactions. This discovery is like finding a hidden oasis in the vast desert of allergic conjunctivitis, offering a potential solution for those seeking relief from this common eye condition.

Azelastine: A Promising Option for Allergic Eye Care

This research suggests that azelastine eye drops could be a valuable addition to the treatment options for allergic conjunctivitis. The study's findings provide promising insights into the potential of azelastine to effectively manage this common eye condition. While further research is warranted to fully understand the long-term effects of azelastine, this study offers a potential solution for those seeking relief from allergic conjunctivitis.

Dr.Camel's Conclusion

This research offers a glimpse of hope for those battling the discomfort of allergic conjunctivitis. The study's findings suggest that azelastine eye drops could be a valuable tool in managing this common eye condition, potentially offering relief from the symptoms and improving quality of life. Remember, just as a camel adapts to the harsh and unpredictable desert environment, individuals with allergic conjunctivitis can find relief with the help of medications like azelastine.

Date :
  1. Date Completed 1997-05-29
  2. Date Revised 2012-11-15
Further Info :

Pubmed ID

9061218

DOI: Digital Object Identifier

9061218

Related Literature

Article Analysis
・Effects of azelastine ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.